Biostar Pharmaceuticals, Inc. Research and Development Expense
Biostar Pharmaceuticals, Inc. reported Research and Development Expense of $1.14 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-04-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2017-04-13
- Biostar Pharmaceuticals, Inc. research and development expense for the quarter ending 2016-12-31 was $1.14M, a 17.05% increase year-over-year.
- Biostar Pharmaceuticals, Inc. research and development expense for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Biostar Pharmaceuticals, Inc. research and development expense for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- Biostar Pharmaceuticals, Inc. research and development expense for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Biostar Pharmaceuticals, Inc. research and development expense for fiscal 2016 was $1.14M, a 71.55% decline from fiscal 2015.
- Biostar Pharmaceuticals, Inc. research and development expense for fiscal 2015 was $4.02M, a 45.36% increase from fiscal 2014.
- Biostar Pharmaceuticals, Inc. research and development expense for fiscal 2014 was $2.77M, a 14.33% decline from fiscal 2013.
- Biostar Pharmaceuticals, Inc. research and development expense for fiscal 2013 was $3.23M, a 27.86% decline from fiscal 2012.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2016-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $1.14M derived: sum of 2 quarters · filed 2017-04-13 | $1.14M derived: sum of 3 quarters · filed 2017-04-13 | $1.14M 10-K · filed 2017-04-13 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-21 | $0.00 derived: sum of 2 quarters · filed 2016-11-21 | $0.00 10-Q · filed 2016-11-21 | $977.37K derived: sum of 4 quarters · filed 2017-04-13 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-22 | $0.00 10-Q · filed 2016-08-22 | $977.37K derived: sum of 3 quarters · filed 2017-04-13 | $1.98M derived: sum of 4 quarters · filed 2017-04-13 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-23 | $977.37K derived: sum of 2 quarters · filed 2017-04-13 | $1.98M derived: sum of 3 quarters · filed 2017-04-13 | $3.00M derived: sum of 4 quarters · filed 2017-04-13 |
| 2015-12-31 | $977.37K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $1.98M derived: sum of 2 quarters · filed 2017-04-13 | $3.00M derived: sum of 3 quarters · filed 2017-04-13 | $4.02M 10-K · filed 2017-04-13 |
| 2015-09-30 | $998.75K 10-Q · filed 2016-11-21 | $2.02M derived: sum of 2 quarters · filed 2016-11-21 | $3.04M 10-Q · filed 2016-11-21 | $3.74M derived: sum of 4 quarters · filed 2016-11-21 |
| 2015-06-30 | $1.03M 10-Q · filed 2016-08-22 | $2.04M 10-Q · filed 2016-08-22 | $2.74M derived: sum of 3 quarters · filed 2016-08-22 | $3.43M derived: sum of 4 quarters · filed 2016-08-22 |
| 2015-03-31 | $1.02M 10-Q · filed 2016-05-23 | $1.71M derived: sum of 2 quarters · filed 2016-05-23 | $2.40M derived: sum of 3 quarters · filed 2016-05-23 | $3.09M derived: sum of 4 quarters · filed 2016-05-23 |
| 2014-12-31 | $691.54K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $1.38M derived: sum of 2 quarters · filed 2016-04-14 | $2.07M derived: sum of 3 quarters · filed 2016-04-14 | $2.77M 10-K · filed 2016-04-14 |
| 2014-09-30 | $690.19K 10-Q · filed 2015-11-23 | $1.38M derived: sum of 2 quarters · filed 2015-11-23 | $2.07M 10-Q · filed 2015-11-23 | $2.89M derived: sum of 4 quarters · filed 2015-11-23 |
| 2014-06-30 | $689.49K 10-Q · filed 2015-08-19 | $1.38M 10-Q · filed 2015-08-19 | $2.20M derived: sum of 3 quarters · filed 2015-08-19 | $3.01M derived: sum of 4 quarters · filed 2015-08-19 |
| 2014-03-31 | $694.94K 10-Q · filed 2015-05-15 | $1.51M derived: sum of 2 quarters · filed 2015-05-15 | $2.32M derived: sum of 3 quarters · filed 2015-05-15 | $3.13M derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | $816.15K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $1.63M derived: sum of 2 quarters · filed 2015-04-15 | $2.43M derived: sum of 3 quarters · filed 2015-04-15 | $3.23M 10-K · filed 2015-04-15 |
| 2013-09-30 | $811.01K 10-Q · filed 2014-11-14 | $1.62M derived: sum of 2 quarters · filed 2014-11-14 | $2.41M 10-Q · filed 2014-11-14 | $4.52M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $805.61K 10-Q · filed 2014-08-14 | $1.60M 10-Q · filed 2014-08-14 | $3.71M derived: sum of 3 quarters · filed 2014-08-14 | $4.50M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $796.00K 10-Q · filed 2014-05-15 | $2.90M derived: sum of 2 quarters · filed 2014-05-15 | $3.69M derived: sum of 3 quarters · filed 2014-05-15 | $4.48M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $2.89M derived: sum of 2 quarters · filed 2014-03-31 | $3.68M derived: sum of 3 quarters · filed 2014-03-31 | $4.48M 10-K · filed 2014-03-31 |
| 2012-09-30 | $789.70K 10-Q · filed 2013-11-14 | $1.58M derived: sum of 2 quarters · filed 2013-11-14 | $2.37M 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $789.78K 10-Q · filed 2013-08-19 | $1.58M 10-Q · filed 2013-08-19 | ||
| 2012-03-31 | $791.13K 10-Q · filed 2013-05-15 | |||
| 2011-12-31 | $2.32M 10-K · filed 2013-04-15 | |||
| 2010-12-31 | $36.11K 10-K · filed 2012-03-27 |